View Item 

Show simple item record

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group
dc.contributor.authorEhrlich, Peter F.
dc.contributor.authorChi, Yueh‐yun
dc.contributor.authorChintagumpala, Murali M.
dc.contributor.authorHoffer, Fredric A.
dc.contributor.authorPerlman, Elizabeth J.
dc.contributor.authorKalapurakal, John A.
dc.contributor.authorTornwall, Brett
dc.contributor.authorWarwick, Anne
dc.contributor.authorShamberger, Robert C.
dc.contributor.authorKhanna, Geetika
dc.contributor.authorHamilton, Thomas E.
dc.contributor.authorGow, Kenneth W.
dc.contributor.authorPaulino, Arnold C.
dc.contributor.authorGratias, Eric J.
dc.contributor.authorMullen, Elizabeth A.
dc.contributor.authorGeller, James I.
dc.contributor.authorGrundy, Paul E.
dc.contributor.authorFernandez, Conrad V.
dc.contributor.authorDome, Jeffrey S.
dc.date.accessioned2020-08-10T20:56:31Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-08-10T20:56:31Z
dc.date.issued2020-08-01
dc.identifier.citationEhrlich, Peter F.; Chi, Yueh‐yun ; Chintagumpala, Murali M.; Hoffer, Fredric A.; Perlman, Elizabeth J.; Kalapurakal, John A.; Tornwall, Brett; Warwick, Anne; Shamberger, Robert C.; Khanna, Geetika; Hamilton, Thomas E.; Gow, Kenneth W.; Paulino, Arnold C.; Gratias, Eric J.; Mullen, Elizabeth A.; Geller, James I.; Grundy, Paul E.; Fernandez, Conrad V.; Dome, Jeffrey S. (2020). "Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group." Cancer 126(15): 3516-3525.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/156248
dc.publisherLippincott Williams and Wilkins
dc.publisherWiley Periodicals, Inc.
dc.subject.otherrenal tumors
dc.subject.otherWilms tumor (WT)
dc.subject.otherBeckwith- Wiedemann syndrome (BWS)
dc.subject.otherpartial nephrectomy
dc.subject.otherpediatric
dc.subject.otherpredisposition syndrome
dc.subject.otherWilms tumor/aniridia/genitourinary anomalies/range of developmental delays (WAGR) syndrome
dc.titleResults of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156248/2/cncr32958_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156248/1/cncr32958.pdfen_US
dc.identifier.doi10.1002/cncr.32958
dc.identifier.sourceCancer
dc.identifier.citedreferenceShamberger RC, Haase GM, Argani P, et al. Bilateral Wilms’ tumors with progressive or nonresponsive disease. J Pediatr Surg. 2006; 41: 652 - 657; discussion 652- 657.
dc.identifier.citedreferenceDome JS, Fernandez CV, Mullen EA, et al. Children’s Oncology Group’s 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013; 60: 994 - 1000.
dc.identifier.citedreferenceDome JS, Perlman EJ, Ritchey ML, et al. Renal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 7 th ed. Lippincott Williams and Wilkins; 2015: 753 - 772.
dc.identifier.citedreferenceDome JS, Graf N, Geller JI, et al. Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol. 2015; 33: 2999 - 3007.
dc.identifier.citedreferenceDome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014; 2014: 215 - 223.
dc.identifier.citedreferenceScott RH, Walker L, Olsen OE, et al. Surveillance for Wilms tumour in at- risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006; 91: 995 - 999.
dc.identifier.citedreferenceBreslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993; 21: 172 - 181.
dc.identifier.citedreferenceCoppes MJ, de Kraker J, van Dijken PJ. Bilateral Wilms’ tumor: long- term survival and some epidemiological features. J Clin Oncol. 1989; 7: 310 - 315.
dc.identifier.citedreferenceDome JS, Huff V. Wilms tumor predisposition. GeneReviews. University of Washington, Seattle; 2016.
dc.identifier.citedreferenceBeckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet. 1998; 79: 268 - 273.
dc.identifier.citedreferencePorteus MH, Narkool P, Neuberg D, et al. Characteristics and outcome of children with Beckwith- Wiedemann syndrome and Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2000; 18: 2026 - 2031.
dc.identifier.citedreferenceBrioude F, Kalish JM, Mussa A, et al. Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith- Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018; 14: 229 - 249.
dc.identifier.citedreferenceEhrlich PF, Dome JS, Shamberger RC, et al. Treatment for patients with bilateral, multicentric, or bilaterally- predisposed unilateral Wilms tumor. Children’s Oncology Group; 2006. www.childrensoncologygroup.org
dc.identifier.citedreferenceCoppes MJ, Beckwith JB, Ritchey ML, D- Angio GJ, Green DM, Breslow N. Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer. 1999; 85: 1616 - 1625.
dc.identifier.citedreferencede Kraker J, Graf N, Pein F; International Society of Paediatric Oncology Renal Tumour Study Group (SIOP- RTSG). Wilms Tumor Protocol 2001. SIOP- RTSG; 2001. Available from: www.siop- rtsg.eu. Accessed January 2020.
dc.identifier.citedreferenceEisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45: 228 - 247.
dc.identifier.citedreferenceEhrlich P, Chi YY, Chintagumpala MM, et al. Results of the first prospective multi- institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children’s Oncology Group. Ann Surg. 2017; 266: 470 - 478.
dc.identifier.citedreferenceO- Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979; 35: 549 - 546.
dc.identifier.citedreferenceGreen DM, Grundy PE, Shamberger RC, Ritchey ML, Grundy P, Dome JS. National Wilms Tumor Study Group V protocol. National Wilms Tumor Study Group; 1995. https://memberschildrensoncologygroup.org/Disc/surgery/surgicalHbooks.asp
dc.identifier.citedreferenceGrundy PE, Breslow N, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable- histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005; 23: 7312 - 7321.
dc.identifier.citedreferenceDavila Fajardo R, Oldenburger E, Rube C, et al. Evaluation of boost irradiation in patients with intermediate- risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP- WT- 2001 Registry. Pediatr Blood Cancer. 2018; 65: e27085.
dc.identifier.citedreferenceScott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006; 43: 705 - 715.
dc.identifier.citedreferenceBreslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. Renal failure in the Denys- Drash and Wilms’ tumor- aniridia syndromes. Cancer Res. 2000; 60: 4030 - 4032.
dc.identifier.citedreferenceLange J, Peterson SM, Takashima JR, et al. Risk factors for end stage renal disease in non- WT1- syndromic Wilms tumor. J Urol. 2011; 186: 378 - 386.
dc.identifier.citedreferenceBreslow N, Collins AJ, Ritchey ML. End stage renal failure in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005; 174: 1972 - 1975.
dc.identifier.citedreferenceScalabre A, Bergeron C, Brioude F, et al. Is nephron sparing surgery justified in Wilms tumor with Beckwith- Wiedemann syndrome or isolated hemihypertrophy? Pediatr Blood Cancer. 2016; 63: 1571 - 1577.
dc.identifier.citedreferenceRomao LPR, Pippi Salle JL, Shuman C, et al. Nephron sparing surgery for unilateral Wilms tumor in children with predisposing syndromes: single center experience over 10 years. J Urol. 2012; 188 ( 4 suppl ): 1493 - 1498.
dc.identifier.citedreferenceWu HY, Snyder HM 3rd, D- Angio GJ. Wilms’ tumor management. Curr Opin Urol. 2005; 15: 273 - 276.
dc.identifier.citedreferenceBreslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor- aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003; 21: 4579 - 4585.
dc.identifier.citedreferenceTournade MF, Com- Nougue C, de Kraker J, et al. Optimal duration of preoperative chemotherapy in unilateral nonmetastatic Wilms tumor in children older than six months. Results of the ninth International Society of Pediatric Oncology tumor trial. J Clin Oncol. 2001; 19: 488 - 500.
dc.identifier.citedreferenceMcNeil DE, Brown M, Ching A, Debraun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith- Wiedemann syndromes: a cost- effective model. Med Pediatr Oncol. 2001; 37: 349 - 356.
dc.identifier.citedreferenceChoyke PL, Siegel MJ, Craft AW, Green DM, Debraun MR. Screening for Wilms tumor in children with Beckwith- Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol. 1999; 32: 196 - 200.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr32958.pdf
Size:
196.7KB
Format:
PDF
View/Open
Name:
cncr32958_am.pdf
Size:
513.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.